Immunoglobulin A nephropathy

Clinical trials for Immunoglobulin A nephropathy explained in plain language.

Never miss a new study

Get alerted when new Immunoglobulin A nephropathy trials appear

Sign up with your email to follow new studies for Immunoglobulin A nephropathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 9 Completed 4 Terminated 2

Can a new injection slow kidney damage in IgA nephropathy?

Disease control Not yet recruiting

This trial tests the long-term safety and effectiveness of povetacicept, an investigational drug given as a subcutaneous injection, in adults with immunoglobulin A nephropathy (IgAN), a kidney disease that can lead to kidney failure. Participants who completed the earlier parent …

Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY

Phase 3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC

Immunoglobulin A nephropathy

Get alerted when new Immunoglobulin A nephropathy trials appear

Can a new injection slow kidney damage in IgA nephropathy?